CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-28 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Employee Stock Option (Right to buy) | +225,000 | 225,000 | ||
| 2022-02-28 | Cotreau Violetta SVP, Chief Accounting Officer | Sale | −3,946 | $2.15 | $9K | 29,121 |
| 2022-02-28 | Cotreau Violetta SVP, Chief Accounting Officer | Grant or award | +40,833 | 69,954 | ||
| 2022-02-28 | Cotreau Violetta SVP, Chief Accounting Officer | Grant or award · Employee Stock Option (Right to buy) | +70,000 | 70,000 | ||
| 2022-02-28 | Dahan Michel SVP, Chief Operating Officer | Sale | −6,555 | $2.15 | $14K | 258,995 |
| 2022-02-28 | Dahan Michel SVP, Chief Operating Officer | Grant or award | +50,000 | 308,995 | ||
| 2022-02-28 | Dahan Michel SVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2022-02-28 | Faulkingham Dell SVP, CCO | Sale | −6,479 | $2.15 | $14K | 130,546 |
| 2022-02-28 | Faulkingham Dell SVP, CCO | Grant or award | +50,000 | 180,546 | ||
| 2022-02-28 | Faulkingham Dell SVP, CCO | Grant or award · Employee Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2022-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −6,555 | $2.15 | $14K | 265,748 |
| 2022-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award | +50,000 | 315,748 | ||
| 2022-02-28 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award · Employee Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2022-02-28 | Spellman David A SVP, CFO and Treasurer | Sale | −7,400 | $2.15 | $16K | 69,402 |
| 2022-02-28 | Spellman David A SVP, CFO and Treasurer | Grant or award | +60,000 | 129,402 | ||
| 2022-02-28 | Spellman David A SVP, CFO and Treasurer | Grant or award · Employee Stock Option (Right to buy) | +225,000 | 225,000 | ||
| 2022-01-03 | Cotreau Violetta SVP, Chief Accounting Officer | Sale | −5,833 | $2.29 | $13K | 33,067 |
| 2021-11-01 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +80,200 | 80,200 | ||
| 2021-09-30 | Spellman David A SVP, CFO and Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-08-31 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −1,042 | $2.83 | $3K | 171,219 |
Page 12 of 21 · 405 trades